A2 Healthcare Taiwan Corporation   Report issue

For profit Phase 1 Phase 2
Founded: Tokyo Japan (2014)

Organization Overview

First Clinical Trial
2014
NCT02289300
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

A2 Healthcare Taiwan Corporation